Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  ANTA PHAR       

 SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Company
Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on developing and commercializing products to treat autoimmune diseases. The company's primary product candidate, blisibimod, targets elevated levels of B-cell activating factor, or BAFF, which has been associated with a... 
Sector
Pharmaceuticals
Calendar
11/04Earnings Release
Surperformance© rating of ANTA PHAR
Trading Rating : Investor Rating : -
More about the company
Financials ($)
Sales 2014 -
EBIT 2014 -33,0 M
Net income 2014 -33,8 M
Debt 2014 -
Yield 2014 -
Sales 2015 -
EBIT 2015 -41,2 M
Net income 2015 -42,0 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 0
Capi. / Sales 2015 0
Capitalization 59,1 M
More Financials
Latest news on ANTA PHAR
6d ago ANTHERA PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL COND..
08/06 ANTHERA PHARMACEUTICALS : Reports 2014 Second Quarter Financial Results and Oper..
07/29 ANTHERA PHARMACEUTICALS : Results of Operations and Financial Condition, Financi..
07/28 ANTHERA PHARMACEUTICALS : Reports 2014 Second Quarter Financial Results and Oper..
07/23 ANTHERA PHARMACEUTICALS : Announces Acquisition of Sollpura® liprotamase for Exo..
07/22 ELI LILLY : Anthera Pharmaceuticals Acquires a Novel Investigational Pancreatic ..
07/18 ELI LILLY : Anthera Pharmaceuticals Buys Sollpura (liprotamase) for Exocrine Pan..
07/17 ANTHERA PHARMACEUTICALS : Entry into a Material Definitive Agreement, Financial ..
07/14 ANTHERA PHARMACEUTICALS : Announces Acquisition of Sollpura® (liprotamase) for E..
06/25 ANTHERA PHARMACEUTICALS : Appoints Brian R. Mueller to Board of Directors
06/23 ANTHERA PHARMACEUTICALS : Appoints Brian R. Mueller to Board of Directors
06/13 ANTHERA PHARMACEUTICALS : Change in Directors or Principal Officers, Submission ..
More news
Comments 
Advertisement
Income Statement Evolution
ANTA PHAR : Income Statement Evolution
More Financials
EPS Revisions
ANTA PHAR : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF